Phosphatidylserine (PS) and phosphatidylethanolamine (PE) are two aminophospholipids whose metabolism is inter-related. Both phospholipids are components of mammalian cell membranes and play important roles in biological processes such as apoptosis and cell signaling. PS is synthesized in mammalian cells by base-exchange reactions in which polar head-groups of pre-existing phospholipids are replaced by serine. PS synthase activity resides primarily on mitochondriaassociated membranes and is encoded by two distinct genes. Studies in mice in which each gene has been individually disrupted are beginning to elucidate the importance of these two synthases for biological functions in intact animals. PE is made in mammalian cells by two completely independent major pathways. In one pathway, PS is converted into PE by the mitochondrial enzyme PS decarboxylase. In addition, PE is made via the CDP-ethanolamine pathway in which the final reaction occurs on the endoplasmic reticulum and nuclear envelope. The relative importance of these two pathways of PE synthesis has been investigated in knock-out mice. Elimination of either pathway is embryonically lethal despite normal activity of the other pathway. PE can also be generated from a base-exchange reaction and by the acylation of PE.
mechanism? Many examples are known in mammalian cells in which either the same or a similar enzymatic reaction for the synthesis of a specific phospholipid is encoded by distinct genes, or even more than one biosynthetic pathway exists for a single phospholipid (64). The tissue distribution of the mRNAs encoding the two PS synthases is different suggesting that each PS synthase might have a specific function. Whereas PS synthase-1 is ubiquitously expressed throughout mouse tissues, and is particularly abundant in the kidney, liver and brain, the mRNA encoding PS synthase-2 is most highly expressed in the testis with much lower levels of expression in other tissues such as brain and heart (62, 65, 66). In addition, there are several indications that the two PS synthases differentially regulate phospholipid metabolism. For example, overexpression of PS synthase-1 activity in hepatoma cells increased the rate of incorporation of [ 3 H]serine into PS, consistent with the idea that the amount of PS synthase-1 is rate-limiting for PS synthesis (61). Nevertheless, the cellular content of PS and PE was not increased. The cells were apparently able to compensate for the increased rate of PS synthesis by enhancing the conversion of PS to PE via PS decarboxylase, and by reducing the formation of PE from the CDP-ethanolamine pathway ( Fig. 1 ) (61). In contrast, an equivalent level of over-expression of PS synthase-2 activity in hepatoma cells did not increase the rate of incorporation of [ increased expression of PS synthase-2 would not be expected to increase the rate of PS synthesis. These studies clearly demonstrate that mammalian cells have the ability to implement compensatory mechanisms for ensuring that constant, optimum levels of PE and PS are maintained.
PS and apoptosis. PS exposure on the cell surface is an early event in apoptosis. The PS that is externalized during apoptosis originates from a pool of newly-synthesized PS (67, 68). The rate of PS synthesis has been reported to be increased ~2-fold during apoptosis (68, 69) although there is no direct evidence that PS externalization is required for the initiation of apoptosis. However, over-expression of either PS synthase-1 or PS synthase-2 in CHO cells reduced the number of cells undergoing apoptosis in response to UV irradiation (70) suggesting that the synthesis of PS might protect against apoptosis. When Neuro2a (neuron-like) cells were incubated with docosahexaenoic acid (22:6n-3), the PS content of the cells increased and the number of apoptotic cells was concomitantly reduced (71). The mechanism by which survival was promoted is that an increased PS content of the cells increased the translocation of Raf-1 (a kinase that is involved in apoptosis) (72, 73) to membranes. In other experiments, the requirement of PS synthase-1 and PS synthase-2 for providing the pool of PS that is externalized during apoptosis was investigated in CHO cell mutants that lacked either PS synthase-1 (58, 74), PS synthase-2 (75), or that were deficient in both PS synthases [i.e. contained only 5% of normal serine-exchange activity] (75). In all of these cell lines, the externalization of PS occurred normally upon induction of apoptosis with staurosporine (76) implying that only very low rates of PS synthesis are required for the progression of apoptosis and the accompanying exposure of PS on the cell surface. In addition, the studies demonstrated that the PS that is externalized is not derived specifically from either isoform of PS synthase.
Other properties of PS synthases. The predicted amino acid sequences of the two PS synthases are ~30% identical (59-62) but, not surprisingly in light of the distinct reactions catalyzed, are completely different from the PS synthases of bacteria and yeast. Little is known about the amino acid residues required for PS synthase activity.
However, the individual replacement of 66 polar amino acids of PS synthase-1 with alanines revealed that several amino acids distributed throughout the protein are required for maximum protein stability/activity. Moreover, these studies showed that the binding of L-serine to the enzyme requires Asn-209 (77). Both PS synthase proteins are predicted to contain multiple membrane-spanning domains (61, 75) consistent with the finding that serine-exchange activity is present on microsomal membranes (63, 78-81). Surprisingly, however, both PS synthase proteins are largely absent from the bulk of the endoplasmic reticulum (ER) but are restricted to a domain of the ER called "mitochondria-associated membranes" (MAM) (82). MAM comprise a sub-domain of the ER that comes into transient contact with mitochondrial outer membranes (81) and mediates the import of PS into mitochondria ( Vance, unpublished data).
Phosphatidylethanolamine Synthesis
Mammalian cells employ two major pathways for PE biosynthesis: the CDPethanolamine pathway and the PS decarboxylation pathway (Figs. 1 and 2). PE can also be made by a base-exchange reaction catalyzed by PS synthase-2 although this source of PE is generally considered to be quantitatively insignificant (104) . In addition, lyso-PE can be acylated to PE by a lyso-PE acyltransferase activity (Figs. 1 and 2) (105) . In yeast, this acyltransferase activity is highly enriched in MAM and has been attributed to the acyl-CoA-dependent acyltransferase Ale1p (106) (107) (108) . Although the mammalian ortholog of Ale1 has not yet been identified, a family of uncharacterized related genes is present in mammals (107, 108) . The relative contribution of the PE biosynthetic pathways to cellular PE content has not been firmly established but appears to depend on the cell type. In rat liver/hepatocytes and hamster heart the CDP-ethanolamine pathway has been reported to produce the majority of PE (109) (110) (111) (112) .
In contrast, in many types of cultured cells >80% of PE is apparently made from the decarboxylation of PS via PS decarboxylase (PSD), even when ethanolamine is provided in the culture medium as a substrate for the CDP-ethanolamine pathway (74, 113, 114) . It should be noted, however, that in all studies in which the relative contribution of these two pathways has been evaluated the pool of the immediate precursor of PE was assumed to be homogenously labeled from a radioactive precursor; this assumption is not necessarily valid (115) . All molecular species of PE can be made from both pathways in hepatoma cells and CHO cells although the CDPethanolamine pathway preferentially synthesizes PE containing mono-or di-unsaturated acyl chains at the sn-2 position whereas the PSD pathway preferentially makes PE containing polyunsaturated acyl chains at the sn-2 position (112) .
The CDP-ethanolamine pathway. Ethanolamine is a required precursor of PE synthesis via this pathway. Ethanolamine is required for the growth and survival of some cell types such as hepatocytes (116) , keratinocytes (117) and mammary carcinoma cells (118) although this requirement is not necessarily related to the biosynthesis of PE via the CDP-ethanolamine pathway. Plants, but not mammalian cells, produce ethanolamine via a direct decarboxylation of serine (119) . Consequently, ethanolamine that is used for PE synthesis in animals must be provided from dietary sources. In addition, small amounts of ethanolamine are produced from the degradation of sphingolipids via the action of sphingosine phosphate lyase (120, 121) . The CDPethanolamine pathway for PE synthesis was elucidated by Kennedy and Weiss in 1956 and parallels the CDP-choline pathway for phosphatidylcholine synthesis (122) .
Mammalian genes encoding the three enzymes of the CDP-ethanolamine pathway have been identified [reviewed in (123) ].
The first reaction of the CDP-ethanolamine pathway is catalyzed by the cytosolic, enzyme ethanolamine kinase ( Fig. 1) (124) . One isoform of ethanolamine kinase phosphorylates both ethanolamine and choline. In addition, a cDNA encoding a human ethanolamine kinase that lacks significant choline kinase activity has also been cloned (124) . Mice lacking the ethanolamine-specific kinase have been generated (125) . In these mice, the PE content of the liver was not decreased but litter size was reduced and approximately 20% of the pups died perinatally. Thus, it appears that the dual specificity ethanolamine/choline kinase is, at least partially, able to substitute for the ethanolamine-specific kinase in these knock-out mice.
The rate-limiting reaction of the CDP-ethanolamine pathway for PE synthesis is catalyzed by another cytosolic enzyme, CTP:phosphoethanolamine cytidylyltransferase (the product of the Pcyt2 gene in mice) that converts phosphoethanolamine into CDPethanolamine ( Fig. 1) (126-129) . Under some metabolic conditions, however, the reaction catalyzed by ethanolamine kinase has been reported to be rate-limiting for PE synthesis (124) . The Pcyt2 mRNA is most highly expressed in liver, heart and skeletal muscle. In contrast to CTP:phosphocholine cytidylyltransferase, which is encoded by (Fig. 1) . A human cDNA encoding both choline-and ethanolaminephosphotransferase activity has been isolated (134, 135). The corresponding mRNA is ubiquitously expressed in all human tissues examined and the enzymatic activity resides primarily in the ER (80, 136). A related human cDNA with 60% sequence identity to the dual specificity choline/ethanolamine phosphotransferase was also cloned but this cDNA appears to encode a protein that exhibits only cholinephosphotransferase activity (135) . Thus, until recently it was widely assumed that the dual specificity choline/ethanolamine phosphotransferase provided all of the mammalian ethanolaminephosphotransferase activity. However, this conclusion is probably not valid because another cDNA that encodes a human CDP-ethanolamine-specific phosphotransferase activity has recently been isolated (137) . The mRNA encoding this protein is widely expressed in human tissues, including the cerebellum in the brain.
Expression of the corresponding cDNA in E. coli demonstrated that the gene product uses CDP-ethanolamine to produce PE.
The PS decarboxylation pathway. In contrast to PE synthesis from CDP-ethanolamine, the final step of which occurs on ER membranes, the production of PE via the decarboxylation pathway is restricted to mitochondria. Thus, (at least) two spatially separated pools of PE might exist -one made in the ER, the other made in mitochondria. The mammalian PSD protein is located on the external leaflet of mitochondrial inner membranes (138, 139) . PSD is a member of a small family of decarboxylases that contain an unusual pyruvoyl prosthetic group (140) . The catalytically active form of PSD is produced by an autocatalytic proteolysis reaction in which a precursor protein is cleaved between a glycine and a serine residue within a
LGST motif to generate two subunits (141); the serine is converted into a pyruvoyl moiety at the N-terminus of the resulting alpha subunit. Complementation experiments in a mutant CHO cell line lacking PSD activity identified a cDNA encoding PSD (142) .
In contrast to mammalian cells, in which all PSD activity appears to originate from a single gene, two PSD genes are expressed in yeast. Thus, yeast contains two distinct PSD proteins with no sequence similarity, each exhibiting PSD activity (143, 144) . One of the yeast isoforms, Psd1p, is restricted to the mitochondria, like the mammalian PSD, whereas the other isoform, Psd2, is located in the Golgi/vacuole.
The PS that is used as the substrate for PSD is produced in the ER and MAM (Fig. 2) . The rate-limiting step in the conversion of PS to PE is the transport of newlysynthesized PS to the site of PSD in mitochondria (145) . This transfer requires, first, the movement of newly-made PS to the mitochondrial outer membrane, followed by transbilayer movement across the mitochondrial outer membrane and, finally, transfer to the active site of PSD on the outer leaflet of mitochondrial inner membranes. Although the mechanisms of these translocations of PS have not been unequivocally defined one likely possibility, for which there is some evidence, is that the transfer of PS from MAM to mitochondrial outer membranes occurs via transient membrane contact sites (Fig. 2) (81, 86, 146). The transfer of PS between outer and inner mitochondrial membranes might also occur via membrane contact sites (87, 147). A mutant CHO cell line has been isolated that has a defect in one of the steps involved in the transfer of PS to the site of PSD (148) 91) is required for the import of newly-synthesized PS into mitochondria for decarboxylation [reviewed in (149) ]. The precise role of Met30p in this process is not entirely clear but the ubiquitination of proteins is known to regulate multiple membrane trafficking events in addition to its role in protein degradation (150) .
Compared to other organelle membranes, the mitochondrial inner membrane is enriched in PE. Almost all PE in mitochondria appears to be made in situ in mitochondria, whereas very little PE is imported from the ER (86). PSD-deficient mice do not survive beyond embryonic day 9 indicating that production of PE from the PSD pathway is essential for mouse development (151) . In Psd [reviewed in (153) ]. This biosynthetic pathway includes a unique reaction in which an acyl group at the sn-1 position of acyl-dihydroxyacetone phosphate is replaced with an alkyl group. Whether or not plasmalogen synthesis utilizes precursors from both the CDP-ethanolamine pathway and the PSD pathway is unclear. When radiolabeled serine or ethanolamine was injected into rats, the CDP-ethanolamine pathway was used by heart, liver and kidney for the synthesis of both PE and ethanolamine plasmalogen, whereas the PSD pathway was used solely for PE, but not plasmalogen, synthesis (154) . In contrast, serine served as a precursor of the ethanolamine head-group of both PE and ethanolamine plasmalogen in cultured C6 glioma cells (155).
The regulation of PSD activity, either at the level of gene expression or by posttranslational mechanisms, has not been reported.
Conclusion
New information on PS and PE has elevated these two phospholipids from obscurity to prominence in biology and revealed that these two aminophospholipids play key roles in 
